Results 141 to 150 of about 719,716 (198)

An Immunomodulating Peptide With Potential to Counteract Endometriosis. [PDF]

Aust N Z J Obstet Gynaecol
Agrez M.
europepmc   +1 more source

IL-12-secreting CAR-T cells reprogram the tumor microenvironment and improve efficacy against heterogeneous models of glioblastoma. [PDF]

J Immunother Cancer
Shen S, Mohan AA, Hotchkiss KM, Cook S, Patel K, Moelker E, Puviindran B, Gonzalez AT, Zaidi S, Spellicy S, Schwartz A, Suryadevara C, Wilkinson D, Ayasoufi K, Fecci PE, Sanchez-Perez L, Sampson J, Patel A.   +17 more
europepmc   +1 more source

Serum inflammatory factors as predictors of severity and prognosis in heart failure: A cohort study. [PDF]

Medicine (Baltimore)
Jiang Z, Joseph L, Niu N, Wang H, Liu Z, Zhang L, Geng Z, Mei J, Yu M, Wang Y, Yang S, Wang Z, Xie W, Qu P.   +13 more
europepmc   +1 more source

Perspective on Corticosteroid Use and Interleukin-1 Inhibition With Anakinra in Pericarditis During Pregnancy. [PDF]

JACC Adv
Trotta L, Mascolo R, Paoletta S, Brucato A.   +3 more
europepmc   +1 more source

Soluble cytokine receptor levels in obstructive sleep apnea patients treated with continuous positive airway pressure therapy. [PDF]

Future Sci OA
Kiriluk SH, Freeburg LA, Khan S, McAlpine CS, Cohen O, Kundel V, Saurez-Farinas M, Spinale FG, Shah N.   +8 more
europepmc   +1 more source

Causal relationships between 41 inflammatory cytokines and myopia: a Mendelian randomization study. [PDF]

Int J Ophthalmol
Wu XF, Yu L, Zhang Y, Li S, Li R, Sun LY.   +5 more
europepmc   +1 more source

Semaglutide promotes bone marrow-derived progenitor cell flux towards an anti-inflammatory and pro-regenerative profile in high-risk patients: the SEMA-VR CardioLink-15 trial. [PDF]

Eur Heart J
Park B, Dennis F, He AZ, Krishnaraj A, Bakbak E, Dennis CJ, Pan Y, Misner E, Thayanithy V, Lambotharan B, Lambotharan V, Lambotharan A, Mazer CD, Quan A, Teoh H, Hess DA, Verma S.   +16 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Interleukin 4 receptor: signaling mechanisms

Immunology Today, 1994
Achsah Keegan and colleagues consider the signaling mechanisms utilized by the interleukin 4 (IL-4) receptor and review evidence suggesting that these mechanisms can account for the known responses of hematopoietic and non-hematopoietic cells to IL-4. Most of these data have been obtained from analyses of the ability of IL-4 to regulate the growth of ...
A D, Keegan, K, Nelms, L M, Wang, J H, Pierce, W E, Paul   +4 more
openaire   +2 more sources

Interleukin-4 and interleukin-4 receptor polymorphisms and colorectal cancer risk

European Journal of Cancer, 2007
Interleukin-4 (IL-4) and interleukin-4 receptor (IL-4R) modulate inflammation and are associated with the colorectal adenoma-carcinoma progression and the metastatic capacity. IL-4 also causes a dose-dependent reduction of proliferation in colorectal cancer cells.
LANDI, STEFANO, BOTTARI F, GEMIGNANI, FEDERICA, GIOIA PATRICOLA L, GUINO E, OSORIO A, DE OCA J, CAPELLA G, CANZIAN F, MORENO V.   +9 more
openaire   +2 more sources